Swathi Padmanabhan's practice focuses on capital markets, corporate governance, and federal securities law. She has represented public and private companies and underwriters in a wide range of corporate transactions, including initial public offerings, activist defense and proxy contests, public and private debt offerings, restructurings, tender offers, and exchange offers. In addition, Swathi advises clients on corporate governance, shareholder activism, securities laws, stock exchange rules and regulations, and periodic reporting responsibilities.
Swathi also has significant M&A experience and has represented public and private companies and private equity firms in mergers, acquisitions, divestitures, spin-offs, and joint ventures. She has represented clients in a variety of industries, including health care, life sciences, financial institutions, military, real estate, telecommunications, and the public sector.
Swathi has researched and published several articles pertaining to corporate and technology law matters, including first authoring an article on the importance of strategic technology transfer partnerships with respect to the enabling HPV vaccine technologies in Nature Biotechnology, which at the time of publication officials at the World Health Organization recognized as one of the most rigorous technical analyses written on the subject to date. Swathi serves as a member of the Advisory Council of the Atlanta Symphony Orchestra.
Publications Prior to Jones Day
Tips and Tactics for Transmitting PHI by Email, coauthor, AHLA Connections
Hacking for Lulz: Employing Expert Hackers to Combat Cyber Terrorism, 15 Vand. J. Ent. & Tech. L. 191
Intellectual property, technology transfer and manufacture of low-cost HPV vaccines in India, Nature Biotechnology, Vol. 28
- Vanderbilt University (J.D. 2013); Duke University (A.B. cum laude 2010)